Quercetin-3-O-Glucuronide Alleviates Cognitive Deficit and Toxicity in Aß1-42 -Induced AD-Like Mice and SH-SY5Y Cells.
Mol Nutr Food Res
; 65(6): e2000660, 2021 03.
Article
em En
| MEDLINE
| ID: mdl-33141510
ABSTRACT
SCOPE Alzheimer's disease (AD) is characterized by amyloid-ß (Aß) related imbalance, Tau-hyperphosphorylation, and neuroinflammation, in which Aß and neuroinflammation can induce brain insulin resistance (IR). Gut microbiome disorder is correlated with inflammation in AD. As of yet, there are no effective treatments clinically. Thus, it is focused on the potential benefit of quercetin-3-O-glucuronide (Q3G), a pharmacologically active flavonol glucuronide, on AD treatment by regulating brain IR and the gut microbiome. METHODS AND RESULTS:
AD mice model built through intracerebroventricular injection of Aß1-42 and AD cell model developed through the SH-SY5Y cell line and Aß1-42 are used to explore the protective effects of Q3G on AD. Neurobehavioral test, brain insulin signaling pathway, and high-throughput pyrosequencing of 16S rRNA are assessed. Data show that Q3G attenuates neuroinflammation and brain IR in Aß1-42 -injected mice and relieves apoptosis in Aß1-42 -treated SH-SY5Y cells by interrupting the downstream insulin signaling. Q3G ameliorates Aß accumulation and Tau phosphorylation, restores CREB and BDNF levels in the hippocampus , and reverses Aß1-42 -induced cognitive impairment. Besides, Q3G restores Aß1-42 -induced reduction of short-chain fatty acids (SCFAs) and gut microbiota dysbiosis.CONCLUSION:
Q3G can alleviate brain IR through directly acting on the brain or modulating the gut-brain axis, ultimately to relieve Aß1-42 -induced cognitive dysfunction.Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Quercetina
/
Doença de Alzheimer
/
Disfunção Cognitiva
/
Microbioma Gastrointestinal
/
Neurônios
Limite:
Animals
/
Humans
/
Male
Idioma:
En
Ano de publicação:
2021
Tipo de documento:
Article